214 related articles for article (PubMed ID: 18854401)
21. Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.
Bai X; Miao D; Li J; Goltzman D; Karaplis AC
Endocrinology; 2004 Nov; 145(11):5269-79. PubMed ID: 15284207
[TBL] [Abstract][Full Text] [Related]
22. Fibroblast growth factor 23 is increased in calcium nephrolithiasis with hypophosphatemia and renal phosphate leak.
Rendina D; Mossetti G; De Filippo G; Cioffi M; Strazzullo P
J Clin Endocrinol Metab; 2006 Mar; 91(3):959-63. PubMed ID: 16352682
[TBL] [Abstract][Full Text] [Related]
23. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.
Wolf M; Koch TA; Bregman DB
J Bone Miner Res; 2013 Aug; 28(8):1793-803. PubMed ID: 23505057
[TBL] [Abstract][Full Text] [Related]
24. FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study.
Schouten BJ; Hunt PJ; Livesey JH; Frampton CM; Soule SG
J Clin Endocrinol Metab; 2009 Jul; 94(7):2332-7. PubMed ID: 19366850
[TBL] [Abstract][Full Text] [Related]
25. Effects of vitamin D replacement therapy on serum FGF23 concentrations in vitamin D-deficient women in short term.
Uzum AK; Salman S; Telci A; Boztepe H; Tanakol R; Alagol F; Ozbey NC
Eur J Endocrinol; 2010 Nov; 163(5):825-31. PubMed ID: 20732956
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast growth factor 23, parathyroid hormone, and 1alpha,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism.
Tebben PJ; Singh RJ; Clarke BL; Kumar R
Mayo Clin Proc; 2004 Dec; 79(12):1508-13. PubMed ID: 15595334
[TBL] [Abstract][Full Text] [Related]
27. Hypophosphatemic rickets in opsismodysplasia.
Zeger MD; Adkins D; Fordham LA; White KE; Schoenau E; Rauch F; Loechner KJ
J Pediatr Endocrinol Metab; 2007 Jan; 20(1):79-86. PubMed ID: 17315533
[TBL] [Abstract][Full Text] [Related]
28. Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype.
Bai X; Dinghong Q; Miao D; Goltzman D; Karaplis AC
Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E79-88. PubMed ID: 18984852
[TBL] [Abstract][Full Text] [Related]
29. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.
Endo I; Fukumoto S; Ozono K; Namba N; Tanaka H; Inoue D; Minagawa M; Sugimoto T; Yamauchi M; Michigami T; Matsumoto T
Bone; 2008 Jun; 42(6):1235-9. PubMed ID: 18396126
[TBL] [Abstract][Full Text] [Related]
30. Reciprocal regulation of calcium-/phosphate-regulating hormones in cyclists during the Giro d'Italia 3-week stage race.
Lombardi G; Corsetti R; Lanteri P; Grasso D; Vianello E; Marazzi MG; Graziani R; Colombini A; Galliera E; Corsi Romanelli MM; Banfi G
Scand J Med Sci Sports; 2014 Oct; 24(5):779-87. PubMed ID: 23647316
[TBL] [Abstract][Full Text] [Related]
31. Postzygotic HRAS mutation causing both keratinocytic epidermal nevus and thymoma and associated with bone dysplasia and hypophosphatemia due to elevated FGF23.
Avitan-Hersh E; Tatur S; Indelman M; Gepstein V; Shreter R; Hershkovitz D; Brick R; Bergman R; Tiosano D
J Clin Endocrinol Metab; 2014 Jan; 99(1):E132-6. PubMed ID: 24243633
[TBL] [Abstract][Full Text] [Related]
32. Oral phosphate supplementation corrects hypophosphatemia and normalizes plasma FGF23 and 25-hydroxyvitamin D3 levels in women with chronic metabolic acidosis.
Domrongkitchaiporn S; Disthabanchong S; Cheawchanthanakij R; Niticharoenpong K; Stitchantrakul W; Charoenphandhu N; Krishnamra N
Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):105-12. PubMed ID: 19449283
[TBL] [Abstract][Full Text] [Related]
33. Regulation of serum 1,25(OH)2 vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4.
Gattineni J; Twombley K; Goetz R; Mohammadi M; Baum M
Am J Physiol Renal Physiol; 2011 Aug; 301(2):F371-7. PubMed ID: 21561999
[TBL] [Abstract][Full Text] [Related]
34. Serum phosphate and phosphate-regulatory hormones in COPD patients.
Stroda A; Brandenburg V; Daher A; Cornelissen C; Goettsch C; Keszei A; Dreher M
Respir Res; 2018 Sep; 19(1):183. PubMed ID: 30236113
[TBL] [Abstract][Full Text] [Related]
35. Association of vitamin D and FGF23 with serum ferritin in hypoparathyroid thalassemia: a case control study.
Saki F; Salehifar A; Kassaee SR; Omrani GR
BMC Nephrol; 2020 Nov; 21(1):482. PubMed ID: 33198660
[TBL] [Abstract][Full Text] [Related]
36. Murk Jansen's metaphyseal chondrodysplasia with long-term followup.
Silverthorn KG; Houston CS; Duncan BP
Pediatr Radiol; 1987; 17(2):119-23. PubMed ID: 3562109
[TBL] [Abstract][Full Text] [Related]
37. Abnormalities in renal tubular phosphate handling in children with sickle cell disease.
Raj VM; Freundlich M; Hamideh D; Alvarez O; Seeherunvong W; Abitbol C; Katsoufis C; Chandar J; Ruiz P; Zilleruelo G
Pediatr Blood Cancer; 2014 Dec; 61(12):2267-70. PubMed ID: 25132581
[TBL] [Abstract][Full Text] [Related]
38. Tertiary 'hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients.
Evenepoel P; Naesens M; Claes K; Kuypers D; Vanrenterghem Y
Am J Transplant; 2007 May; 7(5):1193-200. PubMed ID: 17359508
[TBL] [Abstract][Full Text] [Related]
39. Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations.
Yu X; Sabbagh Y; Davis SI; Demay MB; White KE
Bone; 2005 Jun; 36(6):971-7. PubMed ID: 15869926
[TBL] [Abstract][Full Text] [Related]
40. Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.
Marsell R; Grundberg E; Krajisnik T; Mallmin H; Karlsson M; Mellström D; Orwoll E; Ohlsson C; Jonsson KB; Ljunggren O; Larsson TE
Eur J Endocrinol; 2008 Jan; 158(1):125-9. PubMed ID: 18166826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
